3 news items
Immunic Inc. CEO Daniel Vitt Highlights Advances in MS Treatment on World MS Day
IMUX
30 May 24
of the disease. He highlighted Immunic's innovative approach to MS treatment, which targets both inflammation and neuroprotection. This strategy
Immunic to Host MS R&D Day and Participate in Investor Conferences in April
IMUX
4 Apr 24
15-17: Accelerating Bio-Innovation 2024 UK. Dr. Vitt will participate in one-on-one meetings
Immunic to Host MS R&D Day and Participate in Investor Conferences in April
IMUX
4 Apr 24
15-17: Accelerating Bio-Innovation 2024 UK. Dr. Vitt will participate in one-on-one meetings
- Prev
- 1
- Next